Roche Forecasts 2026 Growth, Cites Drug-Pipeline Strength

Date:




The Swiss drugmaker expects sales and core earnings per share to grow at constant currencies this year, partly due to the strength of its drug pipeline.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Poll: Americans are anxious, pessimistic and deeply unhappy with Trump ahead of the midterms

Weeks ahead of Election Day, 71% of U.S. adults...

Video captures chase between emu, police in California

"No two days are the same—" that's what one...

Luke Bryan’s Son Suffers Football Injury

Luke Bryan's son, 18-year-old Bo, will be taking time...